AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) Short Interest Down 25.2% in May

AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) was the target of a significant drop in short interest during the month of May. As of May 31st, there was short interest totalling 10,400 shares, a drop of 25.2% from the May 15th total of 13,900 shares. Based on an average trading volume of 188,700 shares, the short-interest ratio is presently 0.1 days.

AXIM Biotechnologies Stock Performance

AXIM Biotechnologies stock opened at $0.01 on Thursday. AXIM Biotechnologies has a 1 year low of $0.00 and a 1 year high of $0.02. The company’s 50-day simple moving average is $0.01.

AXIM Biotechnologies Company Profile

AXIM Biotechnologies, Inc engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring.